|
|
ix | |
Preface |
|
xi | |
|
|
1 | (152) |
|
1 Introduction: Trends And Issues In Breastfeeding And The Use Of Infant Formula |
|
|
3 | (16) |
|
|
|
3 | (1) |
|
1.2 human milk and infant formula |
|
|
3 | (1) |
|
1.3 history of breastfeeding versus bottle-feeding |
|
|
4 | (4) |
|
1.4 benefits of breastfeeding versus bottle-feeding |
|
|
8 | (3) |
|
1.5 Infant formula manufacturing |
|
|
11 | (3) |
|
1.6 Trends and new developments in infant formula |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
15 | (4) |
|
2 Biochemistry of human milk |
|
|
19 | (42) |
|
|
|
19 | (1) |
|
|
19 | (1) |
|
2.3 Protiens In Human Milk |
|
|
20 | (5) |
|
|
25 | (1) |
|
2.5 Carbohydrates In Human Milk |
|
|
26 | (2) |
|
2.6 Vitamins In Human Milk |
|
|
28 | (5) |
|
2.7 Minerals In Human Milk |
|
|
33 | (5) |
|
2.8 Changes In Chemical Compostion During Lactation |
|
|
38 | (7) |
|
2.9 Major Factors Affecting Chemical Compostion |
|
|
45 | (9) |
|
|
54 | (1) |
|
|
54 | (7) |
|
3 Bioactive Components In Human Milk |
|
|
61 | (20) |
|
|
|
|
61 | (1) |
|
3.2 The Benefits Of Human Milk |
|
|
61 | (1) |
|
3.3 Bioactive Proteins And Peptides |
|
|
62 | (1) |
|
3.4 Types Of Protein In Human Milk |
|
|
63 | (4) |
|
3.5 Bioactive Lipid Components |
|
|
67 | (3) |
|
3.6 Carbohydrate-based bioactive compounds |
|
|
70 | (3) |
|
|
73 | (1) |
|
3.8 Nucleotides, neuropeptides, and other bioactive factors |
|
|
73 | (3) |
|
3.9 Conclusions and future trends |
|
|
76 | (1) |
|
|
77 | (4) |
|
4 Human milk proteomics and lipidomics and human milk microbiome |
|
|
81 | (44) |
|
|
|
|
|
|
4.1 Human milk proteomics |
|
|
81 | (6) |
|
4.2 Human milk lipidomics |
|
|
87 | (20) |
|
4.3 Human milk microbiome |
|
|
107 | (3) |
|
|
110 | (1) |
|
|
111 | (14) |
|
|
125 | (28) |
|
|
|
|
125 | (7) |
|
5.2 Donor women selection |
|
|
132 | (2) |
|
5.3 Collection and storage of human milk |
|
|
134 | (8) |
|
5.4 Processing of human banked milk |
|
|
142 | (5) |
|
|
147 | (1) |
|
|
148 | (5) |
|
Part II Infant formula formulation and processing |
|
|
153 | (88) |
|
6 Formulation guidelines for infant formula |
|
|
155 | (30) |
|
|
|
155 | (5) |
|
6.2 Regulations governing the formulation and nutrient content of infant formula |
|
|
160 | (3) |
|
6.3 Processing and preparation issues and regulation |
|
|
163 | (5) |
|
6.4 Key functional ingredients in infant formula |
|
|
168 | (1) |
|
|
169 | (3) |
|
6.6 Polyunsaturated fatty acids and other fat-related ingredients |
|
|
172 | (3) |
|
6.7 Carbohydrates, prebiotics, probiotics, and oligosaccharides |
|
|
175 | (2) |
|
6.8 Effects of processing on the quality of infant formula |
|
|
177 | (2) |
|
|
179 | (1) |
|
|
179 | (6) |
|
7 Ingredients selection for infant formula |
|
|
185 | (38) |
|
|
|
185 | (6) |
|
7.2 Animal-based ingredients |
|
|
191 | (5) |
|
7.3 Plant-based ingredients |
|
|
196 | (3) |
|
7.4 Selection of ingredients on the basis of their constituents |
|
|
199 | (8) |
|
7.5 Regulations for the selection of new ingredients |
|
|
207 | (3) |
|
7.6 Ingredients as adulterants or contaminants |
|
|
210 | (3) |
|
|
213 | (1) |
|
|
213 | (10) |
|
8 Processing technology for infant formula |
|
|
223 | (18) |
|
|
|
|
223 | (1) |
|
8.2 Powdered infant formula |
|
|
223 | (7) |
|
8.3 Liquid infant formula |
|
|
230 | (3) |
|
8.4 Special needs formula |
|
|
233 | (6) |
|
|
239 | (2) |
|
Part III Infant formula quality issues |
|
|
241 | (154) |
|
9 Component interactions and processing damage during the manufacture of infant formula |
|
|
243 | (12) |
|
|
|
|
243 | (1) |
|
9.2 Component interactions |
|
|
244 | (3) |
|
9.3 Nutritional implications of component interactions |
|
|
247 | (4) |
|
|
251 | (1) |
|
|
252 | (3) |
|
10 Infant formula quality control |
|
|
255 | (26) |
|
|
|
|
255 | (1) |
|
10.2 Quality control systems for infant formula |
|
|
256 | (5) |
|
10.3 Microbiological content of infant formula and control measures |
|
|
261 | (5) |
|
10.4 Chemical contaminants of infant formula |
|
|
266 | (3) |
|
10.5 Water and air as sources of contaminants of infant formula |
|
|
269 | (3) |
|
10.6 Quality control of the nutritional content of infant formula |
|
|
272 | (2) |
|
|
274 | (1) |
|
|
275 | (6) |
|
11 Infant formula product regulation |
|
|
281 | (36) |
|
|
|
|
281 | (2) |
|
11.2 Food law and the regulation system of the People's Republic of China |
|
|
283 | (5) |
|
11.3 Food law and the regulation system of Japan |
|
|
288 | (3) |
|
11.4 Food law and the regulation system of the Codex Alimentarius Commission |
|
|
291 | (2) |
|
11.5 Food law and the regulation system of Australia and New Zealand |
|
|
293 | (6) |
|
11.6 Food law and the regulation system of the United States |
|
|
299 | (6) |
|
11.7 Food law and the regulation system of the European Union |
|
|
305 | (8) |
|
|
313 | (1) |
|
|
314 | (3) |
|
12 Infant formula analysis |
|
|
317 | (48) |
|
|
|
|
|
|
317 | (1) |
|
12.2 Regulations, methodologies, and validation |
|
|
317 | (5) |
|
12.3 Mixing and sampling: batched product versus dry blended product |
|
|
322 | (2) |
|
12.4 Degradation of vitamins/nutrients in opened packages |
|
|
324 | (1) |
|
12.5 Verification of packaging integrity |
|
|
325 | (1) |
|
12.6 Release, stability, and formula verification testing |
|
|
326 | (1) |
|
12.7 Sampling (AOAC 985.30) |
|
|
326 | (3) |
|
12.8 Gross composition (AOAC 986.25) |
|
|
329 | (3) |
|
12.9 Water-soluble vitamins |
|
|
332 | (4) |
|
12.10 Fat-soluble vitamins |
|
|
336 | (3) |
|
|
339 | (2) |
|
|
341 | (1) |
|
12.13 Functional ingredients |
|
|
342 | (4) |
|
12.14 Guidelines for infant formula clinical trials |
|
|
346 | (10) |
|
|
356 | (1) |
|
|
357 | (6) |
|
|
363 | (2) |
|
13 Infant formula and food allergy |
|
|
365 | (30) |
|
|
|
|
|
365 | (1) |
|
13.2 Molecular mechanism of food allergy |
|
|
366 | (5) |
|
13.3 Nutritional issues in infant food allergy |
|
|
371 | (5) |
|
13.4 Cows' milk allergy in infant |
|
|
376 | (3) |
|
13.5 Methods to prevent food allergy in infants |
|
|
379 | (6) |
|
|
385 | (1) |
|
|
385 | (10) |
Index |
|
395 | |